US 10501516
Peptide compound
granted A61KA61K38/00A61K38/16
Quick answer
US patent 10501516 (Peptide compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K38/16, A61P, A61P3/04